Knowledge (XXG)

HT-29

Source 📝

457: 400: 35: 120:
or acids, the differentiation pathways can be closely studied along with their dependence on surrounding conditions. Accordingly, studies of HT-29 cells have shown induced differentation as a result of
149:
Though HT-29 cells can proliferate in cell culture lacking growth factors with a doubling time of around 4 days, the doubling time can be reduced to one day with added
347:
Gout, S; et al. (1 October 2004). "Early enterocytic differentiation of HT-29 cells: biochemical changes and strength increases of adherens junctions".
441: 498: 46:
Initially derived in 1964 by Jorgen Fogh from a 44-year-old Caucasian female, HT-29 cells form a tight monolayer while exhibiting similarity to
192: 153:. The cells have high glucose consumption, and in standard medium containing 25 mM glucose and 10% serum, remain undifferentiated. 434: 221:"Proliferation of the Human Colon Carcinoma Cell Line HT29: Autocrine Growth and Deregulated Expression of the c-myc Oncogene" 527: 491: 255:"HT-29 cells are an in vitro model for the generation of cell polarity in epithelia during embryonic differentiation" 522: 427: 517: 312:
Cohen, E; et al. (August 1999). "Induced differentiation in HT29, a human colon adenocarcinoma cell line".
89: 532: 484: 220: 266: 150: 138: 364: 329: 294: 235: 198: 188: 468: 411: 356: 321: 284: 274: 180: 108:
with rodents. HT-29 cells terminally differentiate into enterocytes with the replacement of
80:
is deregulated, but may have a relation with the growth factor requirements of HT-29 cells.
51: 270: 289: 254: 511: 407: 58:
tumor antigen, but have a mutation in the p53 gene at position 273, resulting in a
20: 184: 456: 360: 47: 130: 126: 105: 97: 325: 137:, with galactose-mediated differentiation also causing the strengthening of 122: 113: 88:
In preclinical research, HT-29 cells have been studied for their ability to
59: 23: 368: 333: 202: 298: 279: 239: 464: 117: 63: 385: 109: 67: 399: 134: 72: 33: 55: 39: 34: 175:
Martínez-Maqueda, D; et al. (2015). "HT29 Cell Line".
472: 415: 219:
Coudray, Anne-Marie; et al. (1 December 1989).
66:. The cells proliferate rapidly in media containing 38:
The p53 protein, shown interacting with a strand of
26:
used extensively in biological and cancer research.
96:, a characteristic that has made HT-29 useful for 259:Proceedings of the National Academy of Sciences 492: 435: 8: 100:cell research. The cells can also be tested 70:, with corresponding high expression of the 499: 485: 442: 428: 116:in cell culture, and with the addition of 288: 278: 177:The Impact of Food Bioactives on Health 162: 214: 212: 170: 168: 166: 7: 453: 451: 396: 394: 92:and thus simulate real colon tissue 471:. You can help Knowledge (XXG) by 414:. You can help Knowledge (XXG) by 14: 42:, is overexpressed in HT-29 cells 455: 398: 179:. Springer. pp. 113–124. 54:. HT-29 cells overproduce the 1: 253:Hirn, M; et al. (1988). 185:10.1007/978-3-319-16104-4_11 386:Cellosaurus entry for HT-29 361:10.1016/j.yexcr.2004.06.008 549: 450: 393: 349:Experimental Cell Research 326:10.1242/jcs.112.16.2657 314:Journal of Cell Science 43: 280:10.1073/pnas.85.1.136 37: 271:1988PNAS...85..136L 76:oncogene. However, 528:Cell biology stubs 151:fetal bovine serum 139:adherens junctions 44: 523:Colorectal cancer 480: 479: 423: 422: 320:(16): 2657–2666. 234:(23): 6566–6571. 194:978-3-319-15791-7 540: 518:Human cell lines 501: 494: 487: 459: 452: 444: 437: 430: 402: 395: 373: 372: 344: 338: 337: 309: 303: 302: 292: 282: 250: 244: 243: 225: 216: 207: 206: 172: 548: 547: 543: 542: 541: 539: 538: 537: 508: 507: 506: 505: 449: 448: 391: 382: 377: 376: 346: 345: 341: 311: 310: 306: 252: 251: 247: 228:Cancer Research 223: 218: 217: 210: 195: 174: 173: 164: 159: 147: 86: 52:small intestine 32: 30:Characteristics 12: 11: 5: 546: 544: 536: 535: 533:Oncology stubs 530: 525: 520: 510: 509: 504: 503: 496: 489: 481: 478: 477: 460: 447: 446: 439: 432: 424: 421: 420: 403: 389: 388: 381: 380:External links 378: 375: 374: 355:(1): 498–510. 339: 304: 265:(1): 136–140. 245: 208: 193: 161: 160: 158: 155: 146: 143: 85: 82: 31: 28: 13: 10: 9: 6: 4: 3: 2: 545: 534: 531: 529: 526: 524: 521: 519: 516: 515: 513: 502: 497: 495: 490: 488: 483: 482: 476: 474: 470: 467:article is a 466: 461: 458: 454: 445: 440: 438: 433: 431: 426: 425: 419: 417: 413: 410:article is a 409: 404: 401: 397: 392: 387: 384: 383: 379: 370: 366: 362: 358: 354: 350: 343: 340: 335: 331: 327: 323: 319: 315: 308: 305: 300: 296: 291: 286: 281: 276: 272: 268: 264: 260: 256: 249: 246: 241: 237: 233: 229: 222: 215: 213: 209: 204: 200: 196: 190: 186: 182: 178: 171: 169: 167: 163: 156: 154: 152: 144: 142: 140: 136: 132: 128: 124: 119: 115: 111: 107: 103: 99: 95: 91: 90:differentiate 83: 81: 79: 75: 74: 69: 65: 62:replacing an 61: 57: 53: 49: 41: 36: 29: 27: 25: 22: 18: 473:expanding it 462: 416:expanding it 408:cell biology 405: 390: 352: 348: 342: 317: 313: 307: 262: 258: 248: 231: 227: 176: 148: 101: 93: 87: 84:Applications 77: 71: 45: 21:colon cancer 16: 15: 48:enterocytes 19:is a human 512:Categories 157:References 131:nocodazole 127:Colchicine 106:xenografts 98:epithelial 145:Culturing 123:forskolin 114:galactose 60:histidine 50:from the 24:cell line 465:oncology 369:15350547 334:10413674 203:29787047 118:butyrate 94:in vitro 64:arginine 299:3277169 267:Bibcode 240:2684395 110:glucose 102:in vivo 68:suramin 367:  332:  297:  290:279498 287:  238:  201:  191:  133:, and 463:This 406:This 224:(PDF) 135:taxol 78:c-myc 73:c-myc 17:HT-29 469:stub 412:stub 365:PMID 330:PMID 295:PMID 236:PMID 199:PMID 189:ISBN 104:via 357:doi 353:299 322:doi 318:112 285:PMC 275:doi 181:doi 112:by 56:p53 40:DNA 514:: 363:. 351:. 328:. 316:. 293:. 283:. 273:. 263:85 261:. 257:. 232:49 230:. 226:. 211:^ 197:. 187:. 165:^ 141:. 129:, 125:, 500:e 493:t 486:v 475:. 443:e 436:t 429:v 418:. 371:. 359:: 336:. 324:: 301:. 277:: 269:: 242:. 205:. 183::

Index

colon cancer
cell line

DNA
enterocytes
small intestine
p53
histidine
arginine
suramin
c-myc
differentiate
epithelial
xenografts
glucose
galactose
butyrate
forskolin
Colchicine
nocodazole
taxol
adherens junctions
fetal bovine serum



doi
10.1007/978-3-319-16104-4_11
ISBN
978-3-319-15791-7

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.